The Tencent-backed internet-of-things platform developer has chosen the New York Stock Exchange for its initial public offering.
Square will purchase a majority stake in music streaming platform Tidal for $297m, four years after SoftBank subsidiary Sprint paid $200m for a 33% stake.
University of Pennyslvania and Caltech are in line for exits when Stanford’s online education spinout lists on the New York Stock Exchange.
The insurer is set for a reverse merger with Reinvent Technology Partners Z to list on the New York Stock Exchange at a valuation of $5bn.
Seek Group, Times Internet and Laureate Education are all in line for exits when the Stanford University online education spinout lists on the New York Stock Exchange.
Marshall Group has exited the provider of anti-money laundering and identity verification software provider in a purchase by AML RightSource.
Intel Capital has exited the cloud network orchestration and automation software provider, which has been bought by DZS.
Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.
Biox Biosciences, Novo, Sanofi and Merck & Co are all in line to exit the immuno-oncology therapy developer, which has filed for a $100m initial public offering.
Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
